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http://www.biomedcentral.com/1471-244X/14/153RESEARCH ARTICLE Open AccessGender differences in the association between
adiposity and probable major depression: a
cross-sectional study of 140,564 UK Biobank
participants
Zia Ul-Haq1,5, Daniel J Smith1, Barbara I Nicholl1, Breda Cullen1, Daniel Martin1, Jason MR Gill1, Jonathan Evans1,
Beverly Roberts2, Ian J Deary2, John Gallacher3, Matthew Hotopf4, Nick Craddock3, Daniel F Mackay1
and Jill P Pell1*Abstract
Background: Previous studies on the association between adiposity and mood disorder have produced
contradictory results, and few have used measurements other than body mass index (BMI). We examined the
association between probable major depression and several measurements of adiposity: BMI, waist circumference
(WC), waist-hip-ratio (WHR), and body fat percentage (BF%).
Methods: We conducted a cross-sectional study using baseline data on the sub-group of UK Biobank participants
who were assessed for mood disorder. Multivariate logistic regression models were used, adjusting for potential
confounders including: demographic and life-style factors, comorbidity and psychotropic medication.
Results: Of the 140,564 eligible participants, evidence of probable major depression was reported by 30,145 (21.5%). The
fully adjusted odds ratios (OR) for obese participants were 1.16 (95% confidence interval (CI) 1.12, 1.20) using BMI, 1.15 (95%
CI 1.11, 1.19) using WC, 1.09 (95% CI 1.05, 1.13) using WHR and 1.18 (95% CI 1.12, 1.25) using BF% (all p < 0.001). There was a
significant interaction between adiposity and gender (p = 0.001). Overweight women were at increased risk of depression
with a dose response relationship across the overweight (25.0-29.9 kg/m2), obese I (30.0-34.9 kg/m2), II (35.0-39.9 kg/m2)
and III (≥40.0 kg/m2) categories; fully adjusted ORs 1.14, 1.20, 1.29 and 1.48, respectively (all p < 0.001). In contrast,
only obese III men had significantly increased risk of depression (OR 1.29, 95% CI 1.08, 1.54, p = 0.006).
Conclusion: Adiposity was associated with probable major depression, irrespective of the measurement used. The
association was stronger in women than men. Physicians managing overweight and obese women should be alert to
this increased risk.
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Both depression and obesity are major public health prob-
lems. Worldwide, more than 350 million individuals suffer
from depression [1]. As a contributor to the burden of
morbidity, it is ranked third globally and first in middle
and high income countries, with morbidity expected to
rise further [2]. In the United Kingdom alone, around 1 in* Correspondence: jill.pell@glasgow.ac.uk
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unless otherwise stated.20 adults experience an episode of depression annually,
and it is the third most common reason by patients to
consult their general practitioner [3]. Major depression
carries a significant economic and health burden [4,5]. It
is associated with increased physical comorbidity [6], re-
duced health-related quality of life (HRQoL) [7], and im-
paired function in work, school and family life [8], as well
as increased mortality [9], including suicides [10]. The
prevalence of obesity is increasing both in the UK and
worldwide [11], leading to suggestions of an “obesity pan-
demic” or “globesity”. As with depression, we know thatLtd. This is an Open Access article distributed under the terms of the Creative
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[12], poor HRQoL [13-15], and higher societal costs [16].
The relationship between these two important public
health problems has been the focus of an increasing
number of studies over recent years, but these studies
have produced inconsistent results [17,18]. Some have
reported positive associations [19] whilst others have
reported negative [20] or no associations [21]. We previ-
ously showed that adiposity was significantly associated
with poor overall HRQoL [13], but this was largely due
to reductions in the physical component of HRQoL,
with the mental component reduced only among mor-
bidly obese and increased among overweight [14]. Fur-
thermore, we found that poor mental health was confined
to obese women under 45 years of age, and the apparent
protective role of being overweight was confined to men
aged 45–59 years [19].
A meta-analysis of population studies reported a pooled
odds ratio (OR) of 1.26 (95% CI 1.17, 1.36) for the associ-
ation between obesity and depression [22]. This associ-
ation was only significant in women (OR 1.32). Of the 17
studies included, 16 used body mass index (BMI) as a
measure of obesity. Another recent meta-analysis reported
a pooled OR of 1.38 (95% CI 1.22, 1.57) for the association
between central obesity and depression [23]. A total of 15
studies were included in this review, of which 14 used
waist circumference (WC) as the measure of central obes-
ity. Several studies showed that the association between
obesity and depression is stronger in women [19,24]. In
contrast, a recent large study demonstrated that adiposity
was a significant predictor of depression only in men [25].
In these two recent meta-analyses, most used self-
reported adiposity measurements, and many were not
adjusted for important potential confounders such as
socio-economic status, physical comorbidity, and use of
psychotropic medications. Only BMI and WC have been
used as measures of adiposity, and they were simply
dichotomized into obese and not obese, thereby losing
information on the relationship across the spectrum of
adiposity such as whether there is a dose relationship.
There is some evidence that the relationship between
adiposity and depression varies according to the level of
adiposity [26] and that waist-to-hip ratio (WHR) and
body fat percentage (BF%) may also be associated with de-
pression [27]. One recent, comparatively smaller German
study (N = 4907) examined the association between obes-
ity and depression, using the continuous measure of BMI,
WC and WHR but not the direct measurement of BF%
[28]. Overall, there is a paucity of larger studies which used
other than BMI measures in exploring this association.
In this study we aimed to investigate the association
between probable major depression and four different
measurements of adiposity (BMI, WC, WHR and BF%),
measured by trained staff using standard procedures andtools, across the whole range of adiposity (from under-
weight to class III obese). We also explored whether the
associations varied by sex among a very large sample
from the UK middle to old aged population, after adjust-
ing for potential confounding factors, including medical
comorbidity, use of psychotropic drugs, social deprivation
and ethnicity.
Methods
Data source
We conducted a cross-sectional study using baseline
data collected on UK Biobank participants. National
Health Service (NHS), UK maintains the records of
almost all individuals of the general population through
general practitioners. Based on these records, about 5
million primary invitations were sent to the eligible indi-
viduals who were living within a reasonable travelling
distance from the assessment centres (see Additional file 1:
Figure S1). UK Biobank recruited 502,682 participants,
aged 40–69 years, via 22 assessment centres across the
United Kingdom between 2006 and 2010. The assessment
of mood disorders was included only in the last two years,
during which 172,751 participants were recruited [29].
Data collection
Participants completed a series of computer based ques-
tionnaires followed by a face to face interview with trained
research staff. The information collected included demo-
graphics (including sex, age, ethnicity, employment status,
and postcode of residence), lifestyle factors (including
smoking status and alcohol consumption), self-reported
physician-diagnosed comorbidities (cardiovascular disease,
hypertension, diabetes and cancer), current medication
and past or current experience of depressive and manic
symptoms.
Anthropometric measurements (including height, weight,
WC, hip circumference and BF%) were measured by
trained data collectors, using standard operating pro-
cedures. BF% was calculated using a Tanita BC-418MA
body composition analyser. WHR was derived by div-
iding WC (measured by a Wessex non-stretchable sprung
tape at the level of the umbilicus) by hip circumference
(measured at the widest point using the same device).
BMI was derived by dividing weight in kilograms (mea-
sured after removal of shoes and heavy outer clothing
using a Tanita BC-418MA device) by the square of
height in metres (measured without shoes using the
Seca 202 device) [30].
Definitions
BMI was classified as; underweight (<18.5 kg/m2), normal-
weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2),
and obese (≥30 kg/m2). Obesity was further classified as
class I (30.0-34.9 kg/m2), class II (35.0-39.9 kg/m2) or class
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normal-weight (<94 cm), overweight (94–101 cm), and
obese (≥102 cm). The corresponding cut-off values for
women were <80, 80–87 and ≥88 cm, respectively. WHR
was classified among men as; normal weight (<0.90), over-
weight (0.90-0.99) or obese (≥1) and the corresponding
cut-off values for women were <0.80, 0.80-0.84 and ≥0.85,
respectively. BF% was classified among men as; normal
weight (<18%), overweight (18-25%) and obese (>25%).
The equivalent cut-off values for women were <25, 25–32
and >32, respectively.
Age was categorised into three groups; 39–49, 50–60,
and 61–70 years. Townsend score quintile (from 1 least
deprived to 5 most deprived) was used as an indicator of
the participant’s socio-economic status. This is a vali-
dated measure which is determined on the basis of post-
code of residence, and is derived from the following
household information collected in the most recent
census; car ownership, the number of people living in a
house, home ownership, and employment status [31].
Frequency of alcohol consumption (daily/almost daily,
3–4 times/week, 1–2 times/week, 1–3 times/month, spe-
cial occasions and never), smoking status (never, former
and current), ethnic group (white, mixed, Asian/Asian
British [Indian, Pakistani, Bangladeshi and other Asian
background], black/black British, Chinese and other) and
employment status (in paid employment, retired, looking
after home, unemployed, not working due to sickness or
disability and student) were self-reported. Comorbidity
was defined as self-report of a doctor’s diagnosis of one or
more of the following conditions; cardiovascular disease
(coronary heart disease or stroke), hypertension, diabetes
or cancer. Text information on all current medications
was used to identify participants taking “any psychotropic
medication” based on a list of 125 eligible generic and pro-
prietary names compiled by three psychiatrists (DS, BC
and DM).
Our classification of probable major depression was
based on criteria published previously by our group [32].
We convened a series of meetings of Biobank-approved
researchers focusing on mental health and cognition
(membership DJS, JPP, DM, NC, JG, MH, BC, BN, DM,
JE, ID and BR) and, after a number of iterations of pro-
posed criteria, a definition for probable major depression
was agreed. It should be noted that this approach repre-
sented a pragmatic synthesis of the data which was avail-
able to us as part of the UK Biobank baseline assessments
and that the validity of this diagnosis is in part supported
by differences between the probable depression group and
controls in terms of gender distribution, socioeconomic
status, self-reported health rating, current depressive
symptoms and smoking status. Probable major depres-
sion and current depressive symptoms were therefore
defined using information from specific questions onthe severity and duration of both depressed mood and
anhedonia, questions on past help-seeking behaviour
for mental health and answers to the Patient Health
Questionnaire (PHQ) [33]. Participants were then
classified as having probable major depression if they
reported a lifetime history of having ever had either
depressed mood for a period of at least two weeks or a
period of at least two weeks of being unenthusiastic/
disinterested (anhedonic); plus they had reported ever
having seen a general practitioner or psychiatrist for
‘nerves, anxiety, depression” in the past. We included
participants who reported one or more eligible epi-
sodes but participants with probable bipolar I or II
disorders were excluded from this study.
This study was conducted under generic approval from
the National Health Service (NHS) National Research Eth-
ics Service (17th June 2011, Ref 11/NW/0382). Participants
provided electronic consent for the baseline assessments,
biochemical samples and future linkage to routine data-
bases. Participants are not provided with individual level
information nor benefit from any future commercial
developments.
Statistical analyses
The differences in depression and other covariates by
adiposity were analysed using the χ2 test for categorical
data, and χ2 test for trend for ordinal data. We examined
the associations between anthropometric measurements
(BMI, WC, WHR and BF%) and probably major depres-
sion, as the outcome, using multivariate logistic regres-
sion models. The association was first adjusted for age,
sex, socio-economic status and ethnicity (model 1), and
was then further adjusted for employment, alcohol
consumption, smoking, presence of comorbidity (CVD,
hypertension, diabetes, cancer) and use of psychotropic
medications (model 2). We tested whether there were
statistically significant interactions between adiposity
and sex, and conducted sub-group analyses accordingly.
The logistic regression model was repeated using BMI,
WC, WHR and sex-specific deciles of BF%. All statis-
tical analyses were performed using Stata version 12.1
(StataCorp, College Station, Texas). For the descriptive
analysis the statistical significance was defined as p < 0.001.
Results
Of the 172,751 UK Biobank participants who were re-
cruited during the last two years, complete information
on mood disorders was available for 140,564 (81.4%).
Overall, the mean age was 57 years (SD 8 years), and
75,093 (53.4%) were women. 30,145 (21.5%) participants
satisfied our criteria for probable major depression:
19,493 (26.0%) women and 10,652 (16.3%) men. Based
on BMI, 33,857 (24.1%) were obese. Using the other
measures, the percentage classified as obese were 46,504
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(64.9%) for BF%. Depression was significantly more preva-
lent among women than men (19,493 [25.7%] versus
10,652 [16.3%], p < 0.001).
Those with probable major depression were more likely
to be obese and were more likely to be women, younger,
deprived, unemployed, white, smoke, report comorbidity,
and use psychotropic medication, but they consumed
alcohol less frequently (all p < 0.001) (Table 1). There was
a positive association whereby probable major depression
was less common in the lower deciles of adiposity and
more common in the higher deciles, and this was more
marked among women (Figure 1). In women, the preva-
lence of depression in the top decile of adiposity was very
consistent across the different anthropometric measure-
ments; 31.6%, 33.5%, 31.2% and 30.6% using BMI, WC,
WHR, and BF% respectively. The corresponding propor-
tions for men were 20.4%, 20.2%, 18.6% and 24.3%, re-
spectively (Figure 1).
In the overall logistic regression analyses, adjusted for
age, sex, socio-economic status and ethnicity (model 1)
there were significant associations between all an-
thropometric measures and probable major depression
(all p-value <0.001) (Table 2). Being overweight or
obese was significantly associated with probable major
depression, and the odds ratio of major depression in
obese participants was very consistent across the an-
thropometric measurements; 1.36, 1.34, 1.30, and 1.32
for BMI, WC, WHR and BF%, respectively (Table 2).
When further adjusted for the potential confounding
effects of employment, alcohol consumption, smoking,
comorbidity (cardiovascular disease, hypertension, dia-
betes, and cancer) and use of psychotropic medications
(model 2), the associations were slightly attenuated.
Nonetheless, participants classified as overweight or
obese (class I, II or III) based on BMI still had signifi-
cantly higher odds of having probable major depres-
sion, compared to normal weight participants, with
evidence of a linear relationship. The odds ratios of
probable major depression were; 1.09, 1.12, 1.21, and
1.39 (all p-value <0.001) for overweight, class I, II and
III obese, respectively. Similarly, using WC, WHR, and
BF%, overweight and obese participants had signifi-
cantly higher odds of probable major depression than
normal-weight participants, with a dose–response rela-
tionship. The odds ratios for the association between
overweight and probable major depression compared
to normal weight remained very consistent across the
anthropometric measurements; 1.09, 1.07, 1.05 and 1.06
for BMI, WC, WHR and BF% respectively. The corre-
sponding odds ratios for obese participants were 1.16,
1.15, 1.09 and 1.18, respectively (Table 2).
There was a significant interaction between adiposity
and sex (p = 0.001). Sub-group analyses by sex showedthat the overall associations were largely driven by
women (Table 2). In contrast, men classified as over-
weight, overall, class I or class II obese on the basis of
their BMI were not at significantly increased risk of with
probable major depression. Only class III obese men had
significantly higher odds of probable major depression,
compared to normal weight men. Similarly, using WC
and BF%, there was no association between being over-
weight and probable major depression in men. Only
obese men had significantly higher odds of probable
major depression. In contrast, using WHR, both over-
weight and obese men were at significantly increased risk
of probable major depression (Table 2). Underweight indi-
viduals were not at significantly increased risk of depres-
sion either overall or by gender-specific sub-group.
When the logistic regression model was repeated using
the BMI, WC, WHR and BF% sex-specific deciles, the
adjusted odds ratios in women illustrated the similar
positive association (Figure 2) as was observed for the
crude frequencies (Figure 1). The adjusted odds ratios
for the top decile of BMI, WC, WHR and BF% were;
1.38, 1.35, 1.16 and 1.67, respectively. In contrast, among
men, other than the top decile of BMI (>33 kg/m2),
there was a straight line indicating no significant rela-
tionship with probable major depression in all anthropo-
metric measurements.
Discussion
Overall, both overweight and obese individuals were sig-
nificantly more likely to have probable major depression
than normal weight participants, irrespective of the
anthropometric measurement used, and independent of
potential confounding factors. There was evidence of a
dose relationship with the risk of depression increasing
with the level of adiposity, above normal weight. Being
underweight was not associated with probable major de-
pression. The relationship between adiposity and depres-
sion varied significantly by sex, such that the overall
association was largely driven by women. In contrast,
only men with class III obesity were at significantly
increased risk of probable major depression.
In recent meta-analyses, increased BMI was associated
with significantly reduced physical health-related quality
of life [14,15]. In contrast, psychological health-related
quality of life was higher among overweight individuals
and reduced significantly in only class III obese. Two
meta-analyses have reported a significant association
between obesity and depression with pooled odds ratios
of 1.38 for 1.26 for BMI [22] and WC [23]. Wiltink et al.
examined the association between obesity and depres-
sion and demonstrated similar positive relationship,
using the different measurements: BMI, WC and WHR
[28]. In another study, Wyshak demonstrated a posi-
tive association between obesity, measured by BF%,
Table 1 Characteristics of the participants by body mass index category
Obese
Underweight Normal-weight Overweight Overall Class I Class II Class III P-value
N = 654 N = 46,121 N = 59,932 N = 33,857 N = 24,458 N = 6,852 N = 2,547
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Probable major depression
No 508 (77.7) 36,622 (79.4) 47,641 (79.5) 25,648 (75.8) 18,912 (77.3) 5,022 (73.3) 1,714 (67.3) <0.001
Yes 146 (22.3) 9,499 (20.6) 12,291 (20.5) 8,209 (24.3) 5,546 (22.7) 1,830 (26.7) 833 (32.7)
Sex
Women 517 (79.1) 29,748 (64.5) 27,380 (45.7) 17,448 (51.5) 11,634 (47.6) 4,089 (59.7) 1,725 (67.7) <0.001
Men 137 (21.0) 16,373 (35.5) 32,552 (54.3) 16,409 (48.5) 12,824 (52.4) 2,763 (40.3) 822 (32.3)
Age (years)
39-49 170 (26.0) 12,200 (26.5) 12,958 (21.6) 7,119 (21.0) 4,970 (20.3) 1,478 (21.6) 671 (26.3) <0.001
50-60 283 (43.3) 16,955 (36.8) 21,091 (35.2) 12,652 (37.4) 8,937 (36.5) 2,654 (38.7) 1,061 (41.7)
61-70 201 (30.7) 16,966 (36.8) 25,883 (43.22) 14,086 (41.6) 10,551 (43.1) 2,720 (39.7) 815 (32.0)
Townsend score quintile
1 (least deprived) 107 (16.4) 8,289 (18.0) 10,552 (17.6) 4,795 (14.2) 3,718 (15.2) 818 (11.9) 259 (10.2) <0.001
2 108 (16.5) 9,580 (20.8) 12,377 (20.7) 6,115 (18.1) 4,632 (18.9) 1,126 (16.4) 357 (14.0)
3 111 (17.0) 9,563 (20.7) 12,795 (21.4) 6,734 (19.9) 4,956 (20.3) 1,314 (19.2) 464 (18.2)
4 160 (24.5) 10,541 (22.9) 13,232 (22.1) 7,828 (23.1) 5,578 (22.8) 1,646 (24.0) 604 (23.7)
5 (most deprived) 168 (25.7) 8,148 (17.7) 10,976 (18.3) 8,385 (24.8) 5,574 (22.8) 1,948 (28.4) 863 (33.9)
Employment status
In paid employment 339 (51.8) 27,597 (59.8) 34,155 (57.0) 18,733 (55.3) 13,651 (55.8) 3,704 (54.1) 1,378 (54.1) <0.001
Retired 186 (28.4) 14,798 (32.1) 21,733 (36.3) 11,743 (34.7) 8,676 (35.5) 2,333 (34.1) 734 (28.8)
Look after home 56 (8.6) 1,796 (3.9) 1,350 (2.3) 813 (2.4) 530 (2.2) 190 (2.8) 93 (3.7)
Unemployed/unpaid 32 (4.9) 1,113 (2.4) 1,509 (2.5) 1,031 (3.1) 673 (2.8) 245 (3.6) 113 (4.4)
Not working (sick/disable) 39 (6.0) 681 (1.5) 1,041 (1.7) 1,431 (4.2) 854 (3.5) 355 (5.2) 222 (8.7) <0.001
Only student status 2 (0.3) 136 (0.3) 144 (0.2) 106 (0.3) 74 (0.3) 25 (0.4) 7 (0.3)
Alcohol consumption
Daily 139 (21.3) 10,604 (23.0) 13,137 (21.9) 5,337 (15.8) 4,296 (17.6) 846 (12.4) 195 (7.7) <0.001
3-4 times/week 127 (19.4) 11,283 (24.5) 14,456 (24.1) 6,528 (19.3) 5,122 (20.9) 1,077 (15.7) 329 (12.9)
1-2 times/week 123 (18.8) 11,419 (24.8) 15,411 (25.7) 8,677 (25.6) 6,398 (26.2) 1,720 (25.1) 559 (21.6)
1-3 times/month 71 (10.9) 4,775 (10.4) 6,345 (10.6) 4,643 (13.7) 3,152 (12.9) 1,065 (15.5) 426 (16.7)
Special occasions only 94 (14.4) 4,587 (10.0) 6,270 (10.5) 5,306 (15.7) 3,299 (13.5) 1,358 (19.8) 649 (25.5)
Never 100 (15.3) 3,453 (7.5) 4,313 (7.2) 3,366 (9.9) 2,191 (9.0) 786 (11.5) 389 (15.3)
Smoking status
Never 387 (59.2) 27,887 (60.5) 32,729 (54.6) 17,652 (52.1) 12,614 (51.6) 3,652 (53.3) 1,386 (54.4) <0.001
Previous 151 (23.1) 13,590 (29.5) 21,537 (35.9) 13,154 (38.9) 9,575 (39.2) 2,638 (38.5) 941 (37.0)
Current 116 (17.7) 4,644 (10.1) 5,666 (9.5) 3,051 (9.0) 2,269 (9.3) 562 (8.2) 220 (8.6)
Ethnicity
White 591 (90.4) 42,911 (93.0) 55,312 (92.3) 30,838 (91.1) 22,382 (91.5) 6,191 (90.4) 2,265 (88.9) <0.001
Mixed 10 (1.5) 377 (0.8) 381 (0.6) 235 (0.7) 161 (0.7) 47 (0.7) 27 (1.1)
Asian/Asian British 28 (4.3) 1,426 (3.1) 1,893 (3.2) 863 (2.6) 653 (2.6) 162 (2.4) 48 (1.9)
Black/Black British 3 (0.5) 651 (1.4) 1,521 (2.5) 1,451 (4.3) 926 (3.8) 355 (5.2) 170 (6.7)
Chinese 6 (0.9) 291 (0.6) 169 (0.3) 38 (0.1) 34 (0.1) 3 (0.0) 1 (0.0)
Other 16 (2.5) 465 (1.0) 656 (1.1) 432 (1.3) 302 (1.2) 94 (1.4) 36 (1.4)
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Table 1 Characteristics of the participants by body mass index category (Continued)
Comorbidity
No 503 (76.9) 35,056 (76.0) 38,488 (64.2) 16,354 (48.3) 12,551 (51.3) 2,920 (42.6) 883 (32.7) <0.001
Yes 151 (23.1) 11,065 (24.0) 21,444 (35.8) 17,503 (51.7) 11,907 (48.7) 3,932 (57.4) 1,664 (65.3)
Psychotropic medication
No 605 (92.5) 43,487 (94.3) 56,091 (93.6) 30,475 (90.0) 22,263 (91.0) 6,059 (88.4) 2,153 (84.5) <0.001
Yes 49 (7.5) 2,634 (5.7) 3,841 (6.4) 3,382 (10.0) 2,195 (9.0) 793 (11.6) 394 (15.5)
BMI: body mass index category (kg/m2); underweight (<18.5), normal-weight (18.5-24.9), overweight (25–29.9), obese (≥30), class I (30–34), class II (35–39), class III
obese (>40), Townsend score, a measure of socio-economic status, p-value; χ2 test for categorical data & p-value for test of trend for ordinal data, Comorbidity
(CVD, hypertension, diabetes, cancer).
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OR 1.70, 95% CI 1.20, 2.39, p = 0.002) [27]. Our findings
are consistent with those of Wiltink et al. [28], in that the
magnitude of the association between obesity and depres-
sion was comparable using a number of different measure-
ments: 1.36, 1.34, 1.30, and 1.32 for BMI, WC, WHR
and BF%, respectively and there was an overall dose
response relationship across the categories from over-
weight to obese III.
We found that the relationship between adiposity and
depression was stronger in women than men. Previous
studies have reported that overweight individuals have
better mental health than normal-weight individuals [34],
but some have found that this was confined to middle-a
c
Figure 1 Frequency (%) of probable major depression by measures of a
deciles; c. Waist to hip ratio deciles; d. Body fat % deciles).aged men [19]. It is plausible that the association may be
causal, and stronger in women. Adiposity can result in
stigma, particularly in women, which is a known risk
factor for depression [35]. Print and electronic media por-
trayals of thin women and larger, muscular men as ideals
may lead to a lower acceptance of increased body weight
among women [36]. It is also plausible that reverse caus-
ation may play a role. Depression may lead to both less
physical activity and over-eating, contributing to obesity
[37]. Physical attractiveness is known to be associated with
depression, and depression may reduce an individual’s
general interest in maintaining their appearance [38]. De-
pressed people are also reported to have more realism or
even to underestimate their physical attractiveness [39]. Inb
d
diposity and sex (a. Body Mass Index deciles; b. Waist Circumference
Table 2 Logistic regression analysis of the adiposity measurements associated with probable major depression
Overall Women Men
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
N = Overall (women, men) OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
BMI category
Underweight 654 (517, 137) 1.00 (0.83, 1.20) 0.972 0.93 (0.77, 1.13) 0.480 0.92 (0.74, 1.13) 0.428 0.89 (0.71, 1.10) 0.281 1.47 (0.98, 2.21) 0.061 1.25 (0.82, 1.93) 0.302
Normal-weight 46,121 (29748,16373) 1 - 1 - 1 - 1 - 1 - 1 -
Overweight 59,932 (27380, 32552) 1.15 (1.11, 1.18) <0.001 1.09 (1.06, 1.13) <0.001 1.20 (1.15, 1.24) <0.001 1.14 (1.10, 1.19) <0.001 1.07 (1.01, 1.12) 0.018 1.02 (0.97, 1.08) 0.480
Obese (overall) 33,857 (17448, 16409) 1.36 (1.32, 1.41) <0.001 1.16 (1.12, 1.20) <0.001 1.43 (1.37, 1.50) <0.001 1.24 (1.19, 1.30) <0.001 1.24 (1.17, 1.32) <0.001 1.05 (0.99, 1.12) 0.134
Class I 24,458 (11634, 12824) 1.29 (1.24, 1.34) <0.001 1.12 (1.08, 1.17) <0.001 1.35 (1.29, 1.42) <0.001 1.20 (1.14, 1.26) <0.001 1.18 (1.11, 1.26) <0.001 1.02 (0.96, 1.10) 0.489
Class II 6,852 (4089, 2763) 1.47 (1.38, 1.56) <0.001 1.21 (1.14, 1.29) <0.001 1.51 (1.41, 1.63) <0.001 1.29 (1.20, 1.40) <0.001 1.38 (1.25, 1.53) <0.001 1.10 (0.99, 1.23) 0.081
Class III 2,547 (1725, 822) 1.82 (1.66, 1.98) <0.001 1.39 (1.27, 1.53) <0.001 1.84 (1.66, 2.04) <0.001 1.48 (1.32, 1.65) <0.001 1.76 (1.50, 2.08) <0.001 1.29 (1.08, 1.54) 0.006
WC category
Normal-weight 56,210 (29235, 26975) 1 - 1 - 1 - 1 - 1 - 1 -
Overweight 37,850 (18932, 18918) 1.13 (1.10, 1.17) <0.001 1.07 (1.03, 1.10) <0.001 1.15 (1.10, 1.20) <0.001 1.09 (1.04, 1.14) <0.001 1.11 (1.05, 1.17) 0.096 1.04 (0.98, 1.10) 0.161
Obese 46,504 (26926, 19578) 1.34 (1.30, 1.39) <0.001 1.15 (1.11, 1.19) <0.001 1.39 (1.33, 1.44) <0.001 1.21 (1.16, 1.26) <0.001 1.28 (1.22, 1.35) <0.001 1.07 (1.02, 1.13) 0.010
WHR category
Normal-weight 50,725 (31941, 18784) 1 - 1 - - 1 - 1 - 1 -
Overweight 56,790 (19336, 37454) 1.14 (1.10, 1.18) <0.001 1.05 (1.02, 1.09) 0.002 1.12 (1.08, 1.17) <0.001 1.05 (1.01, 1.10) 0.024 1.18 (1.13, 1.24) <0.001 1.06 (1.01, 1.12) 0.018
Obese 33,049 (23816, 9233) 1.30 (1.26, 1.35) <0.001 1.09 (1.05, 1.13) <0.001 1.26 (1.21, 1.31) <0.001 1.09 (1.04, 1.13) <0.001 1.46 (1.36, 1.56) <0.001 1.12 (1.04, 1.20) 0.002
BF% category
Normal-weight 10,186 (3829, 6357) 1 - 1 - 1 - 1 - 1 - 1 -
Overweight 39,212 (14774, 24438) 1.07 (1.01, 1.14) 0.016 1.06 (1.00, 1.13) 0.039 1.08 (1.00, 1.18) 0.061 1.10 (1.00, 1.20) 0.039 1.06 (0.98, 1.14) 0.156 1.03 (0.95, 1.12) 0.469
Obese 91,166 (56490, 34676) 1.32 (1.25, 1.40) <0.001 1.18 (1.12, 1.25) <0.001 1.37 (1.26, 1.48) <0.001 1.26 (1.16, 1.37) <0.001 1.27 (1.17, 1.36) <0.001 1.09 (1.00, 1.18) 0.038
OR: Odds ratio; CI: Confidence Interval; Model 1: adjusted by age, sex, socio-economic status, and ethnicity; Model 2 (full adjusted): in addition to the variables in model-1 below variables were added: employment, al-
cohol consumption, smoking, comorbidity (CVD, diabetes, hypertension, cancer), and use of psychotropic medications; BMI: body mass index category (kg/m2); underweight (<18.5), normal-weight (18.5-24.9), over-
weight (25–29.9), obese overall (>30), class I (30–34), class II (35–39), and class III (>40); WC: Waist Circumference category (cm) men/women; normal-weight (<94/<80), overweight (94-101/80-87), obese
(≥102/≥88); WHR: Waist-to-hip ratio category men/women; normal-weight (<0.90/<0.80), overweight (0.90-0.99/0.80-0.84), obese (≥1/≥0.85); BF: Body fat (%) men/women; normal-weight (<18/<25), over-
weight (18-25/25-32), obese (>25/>32).
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Figure 2 Adjusted¶ odds ratio of probable major depression by measures of adiposity and sex (a. Body Mass Index deciles; b. Waist
Circumference deciles; c. Waist to hip ratio deciles; d. Body fat % deciles).
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http://www.biomedcentral.com/1471-244X/14/153contrast, feeling attractive may be protective against de-
pression. Depression is also known to be associated with
neuro-endocrine abnormalities, such as hypercortisolae-
mia, which can contribute to obesity [40]. In this cross-
sectional study, we were unable to establish temporal rela-
tionships and, therefore, could not determine temporal
relationships.
Only a small number of previous studies have exam-
ined the association between level of adiposity and de-
pression and, to our knowledge, this is the first study to
explore the whole range of adiposity (from underweight
to class III obesity), not rely on self-reported adiposity
and use four different measurements of adiposity. Use of
UK Biobank data enabled us to analyze a very large num-
ber of participants recruited from the general population,
and to adjust for a wide range of potential confounders.
The importance of adjusting for medical comorbidity, use
of psychotropic medications, ethnicity and socio-economic
status has been highlighted previously [22,23,28], but this
has rarely been carried out.
Limitations
Inclusion in our study was limited to the participants
who provided complete information on mood. Approxi-
mately 20% of participants provided some but not all of
the answers to questions about depression, anhedonia,duration of symptoms and previous help-seeking behav-
iour and could not be classified with confidence as
having a lifetime history of probable major depression or
not. These individuals were more likely to be of normal-
weight, men, younger, in employment, had a history of
more alcohol use, were more socially deprived, more
likely to be non smokers and did not report medical co-
morbidity as often as those participants who did not pro-
vide complete information. We also acknowledge that our
definition of probable major depression is a pragmatic ap-
proach based on the data which were available to us rather
than a formal structured diagnosis. As such, it is possible
that we may have missed out some participants with a life-
time history of major depression who have never sought
treatment for it. Further, a proportion of people who seek
treatment for “nerves or anxiety” may also have had low
mood and anhedonia without meeting full diagnostic
criteria for major depression. For these reasons, we have
been careful to classify participants in this study with
significant depressive features as ‘probable major depres-
sion’ rather than formally diagnosed ‘major depressive
disorder’.
UK Biobank recruited middle and old aged individuals
(aged 40 to 69 years) from the general population and so
young people or very old people are underrepresented.
Less than 10% of invited individuals were recruited into
Ul-Haq et al. BMC Psychiatry 2014, 14:153 Page 9 of 10
http://www.biomedcentral.com/1471-244X/14/153UK Biobank. UK Biobank is representative of the UK
population in terms of demographics, but may not be
representative in terms of other parameters. However,
this does not, necessarily impact on the generalisability
of the findings. Previously, we reported an association
between being underweight and poor mental health, par-
ticularly in women [19]. The lack of an association with
underweight in this study may reflect a lack of statistical
power due to smaller numbers in this sub-group, or may
be due to the previous study using the General Health
Questionaire (GHQ-12) which is a short screening in-
strument rather than a detailed assessment of mental
health.
Conclusions
Overweight and obese women are significantly more likely
to suffer from probable major depression, and the risk
increases with increasing level of adiposity, even after
adjusting for a range of potential confounders. Physi-
cians managing overweight and obese women should
be alert to this increased risk. Further research is
required into whether the associations are causal, the
direction of causality, and whether obesity interven-
tions can reduce the risk of depression.
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